MEDICINA
Departamento
University of Alabama at Birmingham
Birmingham, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Alabama at Birmingham (14)
2023
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
Future Oncology, Vol. 19, Núm. 27, pp. 1823-1840
-
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
International Journal of Molecular Sciences, Vol. 24, Núm. 10
2022
-
How I treat triple-class refractory multiple myeloma
British Journal of Haematology, Vol. 198, Núm. 2, pp. 244-256
-
Meta-analysis of ciltacabtagene autoleucel versus physician’s choice therapy for the treatment of patients with relapsed or refractory multiple myeloma
Current Medical Research and Opinion, Vol. 38, Núm. 10, pp. 1759-1767
2021
-
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118
2020
-
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Blood, Vol. 136, Núm. 21, pp. 2401-2409
-
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis
JAMA Oncology, Vol. 6, Núm. 11, pp. 1759-1765
2016
-
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis
Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111
2007
-
An intermediate-conductance Ca2+-activated K+ channel mediates B lymphoma cell cycle progression induced by serum
Pflugers Archiv European Journal of Physiology, Vol. 454, Núm. 6, pp. 945-956
2001
-
An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons
Immunity, Vol. 14, Núm. 6, pp. 727-737
2000
-
Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs
Journal of Immunology, Vol. 165, Núm. 5, pp. 2362-2366